S. Chita

发表

Left ventricular dysfunction in the fetus: relation to aortic valve anomalies and endocardial fibroelastosis.

A. Cook, M. Tynan, L. Allan, 1991, British heart journal.

Insecticide susceptibility profile of the principal malaria vector, Anopheles gambiae s.l. (Diptera: Culicidae), in north-central Nigeria.

I. K. Olayemi, A. T. Ande, S. Chita, 2011, Journal of vector borne diseases.

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2020, Lancet.

The DESiGN trial (DEtection of Small for Gestational age Neonate), evaluating the effect of the Growth Assessment Protocol (GAP): study protocol for a randomised controlled trial

D. Lawlor, N. Marlow, S. Cicero, 2019, Trials.

The accuracy of fetal echocardiography in the diagnosis of congenital heart disease.

L. Allan, D. Crawford, R. Anderson, 1989, International journal of cardiology.

The accuracy of fetal echocardiography in of congenital heart disease the diagnosis

Robert H. Anderson, L. Allan, D. Crawford, 1989 .

Prenatal detection of congenital heart disease: factors affecting obstetric management and survival.

L. Allan, D. Crawford, S. Chita, 1988, American journal of obstetrics and gynecology.

Familial recurrence of congenital heart disease in a prospective series of mothers referred for fetal echocardiography.

M. Tynan, L. Allan, D. Crawford, 1986, The American journal of cardiology.

Flecainide in the treatment of fetal tachycardias.

L. Allan, G. Sharland, K. Priestley, 1991, British heart journal.

Doppler assessment of umbilical artery blood flow for the prediction of outcome in fetal cardiac abnormality

L. Allan, D. Crawford, M. Chapman, 1987, British journal of obstetrics and gynaecology.

Prenatal screening forcongenital heart disease

M. Tynan, L. Allan, D. Crawford, 1986 .

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

K. C. Morris, Mohammed Salah Ibrahim, K. Y. Wong, 2022, medRxiv.

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Patricia A. H. Williams, Steve B Jones, K. Y. Wong, 2021, The Lancet.

Tricuspid valve dysplasia or displacement in intrauterine life.

L. Allan, G. Sharland, S. Chita, 1991, Journal of the American College of Cardiology.

Absent pulmonary valve syndrome with ventricular septal defect: role of the arterial duct.

A. Cook, L. Allan, J. Ettedgui, 1990, The American journal of cardiology.

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2021, The Lancet.

Prenatal measurement of cardiothoracic ratio in evaluation of heart disease.

D. Paladini, L. Allan, S. Chita, 1990, Archives of disease in childhood.

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Steve B Jones, K. Y. Wong, Chamil H. Hettiarachchi, 2021, Lancet.

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Scott M Elliott, J. Haughney, V. Libri, 2021, The Lancet.

Factors influencing the outcome of congenital heart disease detected prenatally.

L. Allan, G. Sharland, S. Chita, 1991, Archives of disease in childhood.

Doppler echocardiographic evaluation of the normal human fetal heart.

M. Tynan, L. Allan, D. Crawford, 1987, British heart journal.

Chromosomal anomalies in fetal congenital heart disease

L. Allan, D. Maxwell, S. Chita, 1991, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Prenatal screening for congenital heart disease.

M. Tynan, L. Allan, D. Crawford, 1986, British medical journal.

The use of colour Doppler in fetal echocardiography.

L. Allan, G. Sharland, S. Chita, 1990, International journal of cardiology.

Measurements of the dimensions of the aortic and pulmonary pathways in the human fetus: a correlative echocardiographic and morphometric study.

A. Angelini, S. Ho, L. Allan, 1988, British heart journal.

Clinical Medication Review and Falls in Older People—What Is the Evidence Base?

T. Tatla, N. Tanna, J. Pitkin, 2016 .

Evidence of redistribution of cardiac output in asymmetrical growth retardation

L. Allan, M. Chapman, S. Chita, 1989, British journal of obstetrics and gynaecology.

Coarctation of the aorta in prenatal life: an echocardiographic, anatomical, and functional study.

M. Tynan, L. Allan, D. Crawford, 1988, British heart journal.

Prenatal Detection of Congenital Heart Disease: Factors Affecting Obstetric Management and Survival

L. Allan, D. Crawford, S. Chita, 1988, American journal of obstetrics and gynecology.

fetal heart . evaluation of the normal human Doppler echocardiographic

M. Tynan, L. Allan, D. Crawford, 2005 .

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

K. C. Morris, Michele R. Shaw, Mohammed Salah Ibrahim, 2023, The Lancet.

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

K. Y. Wong, Mohammad A. Qayum, John S. Clouston, 2022, Lancet.

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

K. Y. Wong, Beverley E. Crane, Scott M Elliott, 2021, Lancet.